Skip to content
OpenCapital
Get started

Biohaven BHVN Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)

Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) at other companies

Biogen logo
BiogenBIIB
——

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%
Enterprise value$2.26B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's available-for-sale debt securities - amortized cost (due within one year).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's available-for-sale debt securities - amortized cost (due within one year)?
Biohaven (BHVN) reported available-for-sale debt securities - amortized cost (due within one year) of $150.53M in Q1 2026.
How has Biohaven's available-for-sale debt securities - amortized cost (due within one year) changed year-over-year?
Biohaven's available-for-sale debt securities - amortized cost (due within one year) decreased by 32.9% year-over-year, from $224.29M to $150.53M.
What is the long-term trend for Biohaven's available-for-sale debt securities - amortized cost (due within one year)?
Over 3 years (2022 to 2025), Biohaven's available-for-sale debt securities - amortized cost (due within one year) has grown at a -28.4% compound annual growth rate (CAGR), from $310.51M to $114.11M.